Item 5.03 Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year

On November 30, 2022, Neoleukin Therapeutics, Inc. (the "Company") filed the Amended and Restated Bylaws as approved and adopted by the Company's board of directors (the "Board"). On January 7, 2023, the Company filed updated Amended and Restated Bylaws to correct incorrect references and page numbers within the table of contents, a copy of which is attached hereto as Exhibit 3.1 and is incorporated herein by reference.

Item 9.01 Financial Statements and Exhibits



(d) Exhibits

Number                       Description
3.1                            Amended and Restated Bylaws of Neoleukin Therapeutics, Inc. (as
                             amended and restated on November 30, 2022)
104                          Cover Page Interactive Data File (formatted as Inline XBRL)

--------------------------------------------------------------------------------

© Edgar Online, source Glimpses